myelin-basic-protein and Puerperal-Disorders

Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Gestational Age; Humans; Immunosuppression Therapy; Multiple Sclerosis; Myelin Basic Protein; Pregnancy; Pregnancy Complications; Puerperal Disorders; Rabbits

Lymphocytes from patients with Bell's palsy were shown to undergo significant stimulation when cultured in vitro in the presence of a purely neuritogenic basic protein (P1L) isolated from human peripheral nerve myelin. No sensitization was observed to other neural antigens, namely, another periperal nerve myelin basic protein (P2) and the central nerve myelin basic encephalitogenic protein (BE). A similar pattern of response was also demonstrated in patients with Guillain-Barré syndrome (GBS). Lymphocytes from patients suffering from other neuropathies or other diseases involving the face showed no response to any of these antigens. The specific in vitro response to P1L protein in Bell's palsy may suggest that an in vivo sensitization of lymphocytes to such self protein occurs in this condition, and that cell-mediated, probably post-infectious, autoimmune mechanisms may be an important factor in the pathogenesis of the paralysis. Thus, Bell's palsy is immunologically similar to GBS, or may even represent a mononeuritic variant of GBS. In view of these findings the administration of steroids to patients with Bell's palsy seems logical on the basis of their immunosuppressive action.

Topics: Adolescent; Adult; Diabetes Complications; Facial Paralysis; Female; Humans; Immunity, Cellular; Lectins; Lymphocyte Activation; Male; Middle Aged; Myelin Basic Protein; Nerve Tissue Proteins; Peripheral Nerves; Polyradiculopathy; Prednisone; Pregnancy; Pregnancy Complications; Puerperal Disorders; Receptors, Cholinergic